Skip to main content
Yan Zheng, MD, Pathology, Memphis, TN

YanZhengMD

Pathology Memphis, TN

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Zheng?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 2 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    262 Danny Thomas Pl
    Memphis, TN 38105
    Phone+1 901-595-1145

Summary

  • Dr. Yan Zheng, MD is a board certified pathologist in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee, Connecticut, and Pennsylvania. She is affiliated with St. Jude Children's Research Hospital.

Education & Training

  • Beijing Medical University
    Beijing Medical UniversityClass of 1998

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2017 - 2025
  • PA State Medical License
    PA State Medical License 2015 - 2022
  • CT State Medical License
    CT State Medical License 2016 - 2020
  • NY State Medical License
    NY State Medical License 2008 - 2017
  • OH State Medical License
    OH State Medical License 2013 - 2016
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Blood Banking/Transfusion Medicine
    American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

Press Mentions

  • ILT4 Inhibition Prevents TAM- and Dysfunctional T Cell-Mediated Immunosuppression and Enhances the Efficacy of Anti-PD-L1 Therapy in NSCLC with EGFR Activation
    ILT4 Inhibition Prevents TAM- and Dysfunctional T Cell-Mediated Immunosuppression and Enhances the Efficacy of Anti-PD-L1 Therapy in NSCLC with EGFR ActivationJanuary 19th, 2021
  • LINC00173.v1 Promotes Angiogenesis and Progression of Lung Squamous Cell Carcinoma by Sponging miR-511-5p to Regulate VEGFA Expression
    LINC00173.v1 Promotes Angiogenesis and Progression of Lung Squamous Cell Carcinoma by Sponging miR-511-5p to Regulate VEGFA ExpressionMay 30th, 2020
  • AABBs National Blood Foundation Announces 2019 Early-Career Grant Recipients
    AABBs National Blood Foundation Announces 2019 Early-Career Grant RecipientsJuly 23rd, 2019
  • Join now to see all